These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24356727)

  • 1. Alcohol-induced changes in methylation status of individual CpG sites, and serum levels of vasopressin and atrial natriuretic peptide in alcohol-dependent patients during detoxification treatment.
    Glahn A; Riera Knorrenschild R; Rhein M; Haschemi Nassab M; Gröschl M; Heberlein A; Muschler M; Frieling H; Bleich S; Hillemacher T
    Eur Addict Res; 2014; 20(3):143-50. PubMed ID: 24356727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal.
    Hillemacher T; Frieling H; Luber K; Yazici A; Muschler MA; Lenz B; Wilhelm J; Kornhuber J; Bleich S
    Psychoneuroendocrinology; 2009 May; 34(4):555-60. PubMed ID: 19046820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the promoter methylation of atrial natriuretic peptide and vasopressin in alcohol use disorder. A longitudinal case-control-study during withdrawal therapy.
    Proskynitopoulos PJ; Rhein M; Petersson LP; Sperling CH; Wöhler J; Deest M; Bleich S; Frieling H; Hillemacher T; Glahn A
    Psychoneuroendocrinology; 2021 Nov; 133():105387. PubMed ID: 34399149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and Promoter-Specific Deoxyribonucleic Acid Methylation of the Atrial Natriuretic Peptide Gene: Methylation of Smokers and Non-Smokers Differs Significantly during Withdrawal.
    Glahn A; Rhein M; Frieling H; Schuster R; El Aissami A; Bleich S; Hillemacher T; Muschler M
    Eur Addict Res; 2017; 23(6):306-311. PubMed ID: 29339652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic down regulation of nerve growth factor during alcohol withdrawal.
    Heberlein A; Muschler M; Frieling H; Behr M; Eberlein C; Wilhelm J; Gröschl M; Kornhuber J; Bleich S; Hillemacher T
    Addict Biol; 2013 May; 18(3):508-10. PubMed ID: 21392176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alteration of the dopamine transporter gene in alcohol-dependent patients is associated with age.
    Nieratschker V; Grosshans M; Frank J; Strohmaier J; von der Goltz C; El-Maarri O; Witt SH; Cichon S; Nöthen MM; Kiefer F; Rietschel M
    Addict Biol; 2014 Mar; 19(2):305-11. PubMed ID: 22506971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics.
    Döring WK; Herzenstiel MN; Krampe H; Jahn H; Pralle L; Sieg S; Wegerle E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2003 May; 27(5):849-61. PubMed ID: 12766631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of the LEP gene is associated with craving during alcohol withdrawal.
    Hillemacher T; Weinland C; Lenz B; Kraus T; Heberlein A; Glahn A; Muschler MA; Bleich S; Kornhuber J; Frieling H
    Psychoneuroendocrinology; 2015 Jan; 51():371-7. PubMed ID: 25462909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity.
    Frieling H; Bleich S; Otten J; Römer KD; Kornhuber J; de Zwaan M; Jacoby GE; Wilhelm J; Hillemacher T
    Neuropsychopharmacology; 2008 Oct; 33(11):2605-9. PubMed ID: 18172431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of atrial natriuretic peptide on anxiety, stress and craving in patients with alcohol dependence.
    Koopmann A; Leménager T; Wolf ND; Reinhard I; Hermann D; Koch J; Wiedemann K; Kiefer F
    Alcohol Alcohol; 2014; 49(3):282-6. PubMed ID: 24166646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute alcohol withdrawal and recovery in men lead to profound changes in DNA methylation profiles: a longitudinal clinical study.
    Witt SH; Frank J; Frischknecht U; Treutlein J; Streit F; Foo JC; Sirignano L; Dukal H; Degenhardt F; Koopmann A; Hoffmann S; Koller G; Pogarell O; Preuss UW; Zill P; Adorjan K; Schulze TG; Nöthen M; Spanagel R; Kiefer F; Rietschel M
    Addiction; 2020 Nov; 115(11):2034-2044. PubMed ID: 32080920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving.
    Hillemacher T; Frieling H; Hartl T; Wilhelm J; Kornhuber J; Bleich S
    J Psychiatr Res; 2009 Jan; 43(4):388-92. PubMed ID: 18504048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Control of the Vasopressin Promoter Explains Physiological Ability to Regulate Vasopressin Transcription in Dehydration and Salt Loading States in the Rat.
    Greenwood MP; Greenwood M; Gillard BT; Loh SY; Paton JF; Murphy D
    J Neuroendocrinol; 2016 Apr; 28(4):n/a. PubMed ID: 26833868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do changes in the BDNF promoter methylation indicate the risk of alcohol relapse?
    Heberlein A; Büscher P; Schuster R; Kleimann A; Lichtinghagen R; Rhein M; Kornhuber J; Bleich S; Frieling H; Hillemacher T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1892-7. PubMed ID: 26404404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAT1 methylation changes in alcohol-dependent individuals vs. controls.
    Jasiewicz A; Rubiś B; Samochowiec J; Małecka I; Suchanecka A; Jabłoński M; Grzywacz A
    J Psychiatr Res; 2015 May; 64():130-3. PubMed ID: 25862379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation.
    Lauand F; Ruginsk SG; Rodrigues HL; Reis WL; de Castro M; Elias LL; Antunes-Rodrigues J
    Neuroscience; 2007 Jun; 147(1):247-57. PubMed ID: 17524563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients.
    Glahn A; Heberlein A; Dürsteler-MacFarland KM; Lenz B; Frieling H; Gröschl M; Wiesbeck GA; Kornhuber J; Bönsch D; Bleich S; Hillemacher T
    Neuropsychobiology; 2013; 67(2):111-5. PubMed ID: 23406607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal.
    Costa MA; Girard M; Dalmay F; Malauzat D
    Alcohol Clin Exp Res; 2011 Nov; 35(11):1966-73. PubMed ID: 21848960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.